OpenDNA
Eran Feldhay, MD is the Founder and CEO of OpenDNA since March 2020. Before that, Eran was on the Advisory Board and served as the CMO at Dia Imaging Analysis from August 2018 to March 2022. Eran also held the position of Chairman at Maverick Medical AI from January 2018 to July 2020. At apifix, where Eran was the CEO from October 2016 to February 2018, the company was acquired by Orthopediatrics in 2020, disrupting the Scoliosis surgery market. Eran's experience also includes being the CEO at Trendlines Medical, the Medcon GM & VP Cardiology at Medcon a McKESSON company, and VP marketing and product management at Medcon. Eran holds an MD in Medicine from Tel Aviv University and an MBA from Ben-Gurion University of the Negev.
This person is not in any teams
This person is not in any offices
OpenDNA
OpenDNA has created a cloud based precision genomic medicine platform for cardiovascular disease and diabetes that uses AI algorithms to predict risk and provide personalized treatments to patients. We believe the future of medicine is using data to improve patient outcomes and to reduce healthcare costs